Presentation Information
[O2-05]Impact and cost-effectiveness of maternal vaccine and short and long-acting monoclonal antibodies against respiratory syncytial virus among children in Japan: a modeling study
*Noriko Kitamura1, Motoi Suzuki1, Kaja Abbas2 (1. Center for Infectious Disease Epidemiology, NIID, JIHS (Japan), 2. Department of Infectious Disease Dynamics, Institute of Tropical Medicine, Nagasaki University (Japan))

Keywords:
Respiratory Syncytial Virus,vaccine,monoclonal antibodies,cost-effectiveness
Password required to view
Log in
or
Comment
To browse or post comments, you must log in.Log in
